Drug intelligence / Profile preview

5B1-FL800

Development stage
Preclinical
Lead developer
Memorial Sloan Kettering Cancer Center
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

5B1-FL800 is a near-infrared fluorescent (NIRF) imaging agent consisting of the fully human monoclonal antibody 5B1 conjugated to the fluorescent dye IRDye800CW. The antibody 5B1 specifically targets Carbohydrate Antigen 19-9 (CA19.9), a biomarker highly expressed in pancreatic ductal adenocarcinoma (PDAC) and other gastrointestinal cancers. Developed by Memorial Sloan Kettering Cancer Center in collaboration with MabVax Therapeutics, 5B1-FL800 is designed for intraoperative imaging to assist surgeons in identifying tumor margins, detecting occult metastases, and guiding the resection of pancreatic cancer. In preclinical studies, it has demonstrated high specificity and a high signal-to-background ratio, enabling the visualization of small tumor deposits invisible to the naked eye.

Other names
IRDye800CW-5B1IRDye-800CW-5B1IRDye 800CW-5B1anti-CA19.9-IRDye800CWanti-CA-19.9-IRDye800CWanti-CA 19.9-IRDye800CW

Beyond the preview

Go deeper on 5B1-FL800.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5B1-FL800.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call